Nicholas M. Croft

3.6k total citations
57 papers, 1.5k citations indexed

About

Nicholas M. Croft is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Nicholas M. Croft has authored 57 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Genetics, 21 papers in Epidemiology and 13 papers in Surgery. Recurrent topics in Nicholas M. Croft's work include Inflammatory Bowel Disease (30 papers), Microscopic Colitis (19 papers) and Adolescent and Pediatric Healthcare (13 papers). Nicholas M. Croft is often cited by papers focused on Inflammatory Bowel Disease (30 papers), Microscopic Colitis (19 papers) and Adolescent and Pediatric Healthcare (13 papers). Nicholas M. Croft collaborates with scholars based in United Kingdom, Netherlands and United States. Nicholas M. Croft's co-authors include Thomas T. MacDonald, Giovanni Monteleone, Catriona McKenzie, H W Steer, James O. Lindsay, Ian R. Sanderson, James Goodhand, Charlotte Hedin, Martin O. Savage and Cecilia Camacho‐Hübner and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and The Journal of Immunology.

In The Last Decade

Nicholas M. Croft

54 papers receiving 1.5k citations

Peers

Countries citing papers authored by Nicholas M. Croft

Since Specialization

Citations

This map shows the geographic impact of Nicholas M. Croft's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicholas M. Croft with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicholas M. Croft more than expected).

Fields of papers citing papers by Nicholas M. Croft

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicholas M. Croft. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicholas M. Croft. The network helps show where Nicholas M. Croft may publish in the future.

Co-authorship network of co-authors of Nicholas M. Croft

This figure shows the co-authorship network connecting the top 25 collaborators of Nicholas M. Croft. A scholar is included among the top collaborators of Nicholas M. Croft based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicholas M. Croft. Nicholas M. Croft is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Gut-homing and intestinal TIGITnegCD38+ memory T cells acquire an IL-12-induced, ex-Th17 pathogenic phenotype in a subgroup of Crohn’s disease patients with a severe disease course 2024 ·Mucosal Immunology ·(unknown), (unknown), Irma Tindemans, (unknown), M Aardoom, (unknown), L M M Costes, Maria E. Joosse, (unknown), (unknown), L A van Berkel, Polychronis Kemos, Frank M. Ruemmele, Nicholas M. Croft, Johanna C. Escher, Lissy de Ridder, Janneke N. Samsom	1
2	The Risk of Venous Thromboembolism in Children With Inflammatory Bowel Disease 2024 ·Inflammatory Bowel Diseases ·Philip Harvey, David McNulty, (unknown), Polychronis Kemos, Nicholas M. Croft, Nigel Trudgill	2
3	Validation of predictive models for disease outcomes in paediatric ulcerative colitis: A multicentre prospective inception cohort 2023 ·Alimentary Pharmacology & Therapeutics ·Ohad Atia, (unknown), Lissy de Ridder, Polychronis Kemos, Frank M. Ruemmele, Ben Kang, Sujin Choi, Byung‐Ho Choe, Youra Kang, Dror S. Shouval, Gili Focht, Oren Ledder, Raffi Lev‐Tzion, (unknown), (unknown), Dan Turner, Nicholas M. Croft, Esther Orlanski‐Meyer	4
4	Safety and efficacy of multimatrix mesalamine in paediatric patients with mild-to-moderate ulcerative colitis: a phase 3, randomised, double-blind study 2023 ·EClinicalMedicine ·Nicholas M. Croft, Bartosz Korczowski, Jarosław Kierkuś, Beatriz Caballero, Manoj Kumar Thakur	2
5	Thromboprophylaxis Use in Paediatric Inflammatory Bowel Disease: An International RAND Appropriateness Panel 2022 ·Journal of Crohn s and Colitis ·Franco Torrente, Susanna Meade, Eric I. Benchimol, Lissy de Ridder, Nicholas M. Croft, Jochen Kammermeier, David R. Mack, (unknown), Dan Turner, David C. Wilson, Javier Martín‐de‐Carpi, Jiří Bronský, Jorge Amil Dias, Gregor Walker, C. Heleen van Ommen, (unknown), (unknown), Peter M. Irving, Mark Samaan, Richard Hansen	7
6	Bridging Fixed Dose to Body Weight-based Regimen of Adalimumab in Paediatric Ulcerative Colitis Using a Pharmacometric Modelling Approach: Case Study with the Phase 3 ENVISION I Trial 2022 ·Journal of Crohn s and Colitis ·Sven Stodtmann, (unknown), (unknown), (unknown), Andreas Lazar, Nicholas M. Croft, Jarosław Kierkuś, William A. Faubion, Nael M. Mostafa	1
7	Identifying Health Economic Considerations to Include in the Research Protocol of a Randomized Controlled Trial (the REDUCE-RISK Trial): Systematic Literature Review and Assessment 2020 ·JMIR Formative Research ·Mattias Neyt, (unknown), Marina Aloi, Lissy de Ridder, Nicholas M. Croft, Sibylle Koletzko, Arie Levine, Dan Turner, Richard K. Russell, Frank M. Ruemmele, Gigi Veereman	1
8	International prospective observational study investigating the disease course and heterogeneity of paediatric-onset inflammatory bowel disease: the protocol of the PIBD-SETQuality inception cohort study 2020 ·BMJ Open ·M Aardoom, Polychronis Kemos, Irma Tindemans, Marina Aloi, Sibylle Koletzko, Arie Levine, Dan Turner, (unknown), Mattias Neyt, Richard K. Russell, Thomas D. Walters, Frank M. Ruemmele, Janneke N. Samsom, Nicholas M. Croft, Lissy de Ridder	9
9	Protocol for a multinational risk-stratified randomised controlled trial in paediatric Crohn’s disease: methotrexate versus azathioprine or adalimumab for maintaining remission in patients at low or high risk for aggressive disease course 2020 ·BMJ Open ·Rachel E. Harris, Marina Aloi, Lissy de Ridder, Nicholas M. Croft, Sibylle Koletzko, Arie Levine, Dan Turner, Gigi Veereman, Mattias Neyt, (unknown), Frank M. Ruemmele, Richard K. Russell	6
10	Adolescents with IBD: The importance of structured transition care 2011 ·Journal of Crohn s and Colitis ·James Goodhand, Charlotte Hedin, Nicholas M. Croft, James O. Lindsay	91
11	A qualitative study of the early effects of fixed orthodontic treatment on dietary intake and behaviour in adolescent patients 2011 ·European Journal of Orthodontics ·(unknown), Susan Cunningham, Nicholas M. Croft, Ama Johal	51
12	Inhibition of NF-κB Signaling in Human Dendritic Cells by the Enteropathogenic Escherichia coli Effector Protein NleE 2010 ·The Journal of Immunology ·Anna Vossenkämper, Olivier Marchès, Peter D. Fairclough, Gary Warnes, Andrew J. Stagg, James O. Lindsay, Paul C. Evans, Le Anh Luong, Nicholas M. Croft, Sandhia Naik, Gad Frankel, Thomas T. MacDonald	65
13	Evidence for the Role of Interferon-alfa Production by Dendritic Cells in the Th1 Response in Celiac Disease 2007 ·Gastroenterology ·Antonio Di Sabatino, Karen Pickard, J Gordon, V.M. Salvati, Giuseppe Mazzarella, R Mark Beattie, (unknown), L. Rovedatti, N. Leakey, Nicholas M. Croft, Riccardo Troncone, Gino Roberto Corazza, Andrew J. Stagg, Giovanni Monteleone, Thomas T. MacDonald	101
14	Genetically modified enterotoxigenic Escherichia coli vaccines induce mucosal immune responses without inflammation 2007 ·Gut ·Andrew J. Daley, Roger Randall, Michael J. Darsley, Naheed Choudhry, (unknown), Ian R. Sanderson, Nicholas M. Croft, Paul Kelly	24
15	The Anti‐Inflammatory Effects of Enteral Nutrition 2005 ·Journal of Parenteral and Enteral Nutrition ·Ian R. Sanderson, Nicholas M. Croft	32
16	Anti-Inflammatory and Growth-Stimulating Effects Precede Nutritional Restitution During Enteral Feeding in Crohn Disease 2004 ·Journal of Pediatric Gastroenterology and Nutrition ·(unknown), Cecilia Camacho‐Hübner, (unknown), (unknown), Ray Edwards, Martin O. Savage, Ian R. Sanderson, Nicholas M. Croft	140
17	Blocking Smad7 restores TGF-β1 signaling in chronic inflammatory bowel disease 2001 ·Journal of Clinical Investigation ·Giovanni Monteleone, (unknown), Nicholas M. Croft, Catriona McKenzie, H W Steer, Thomas T. MacDonald	26
18	Blocking Smad7 restores TGF-β1 signaling in chronic inflammatory bowel disease 2001 ·Journal of Clinical Investigation ·Giovanni Monteleone, (unknown), Nicholas M. Croft, Catriona McKenzie, H W Steer, Thomas T. MacDonald	493
19	Microvillous Inclusion Disease: An Evolving Condition 2000 ·Journal of Pediatric Gastroenterology and Nutrition ·Nicholas M. Croft, Allan G. Howatson, Simon C. Ling, Lesley Nairn, Tom Evans, Lawrence T. Weaver	35
20	Zidovudine Therapy in Combination with Intravenous Immunoglobulin in HIV Infected Children 1992 ·Scottish Medical Journal ·Nicholas M. Croft, P.L. Yap, J Y Mok, R A Hague, S. M. Burns	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact